Status:
TERMINATED
Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Bone Scan
Eligibility:
All Genders
15+ years
Brief Summary
This study is being done to provide an alternative to bone scanning with technetium-99m (99mTc) labelled diphosphonates, and to document the safety of {18F}-Sodium Fluoride (Na18F) as a Positron Emiss...
Detailed Description
18F-Sodium Fluoride (Na18F) PET imaging is a nuclear medicine procedure, and its principal radiopharmaceutical, Na18F, has been used for scanning the skeleton for the spread of cancer for more that 30...
Eligibility Criteria
Inclusion
- Male or female patient for whom 99mTc-MDP bone scans would normally be indicated
- If female of child-bearing potential and outside the window of 10 days since the last menstrual period, a negative serum or urine pregnancy test is required.
- Age greater than or equal to 15 years
- Able and willing to follow instructions and comply with the protocol
- Provide written informed consent prior to participation in the study
- If an oncology patient, the patient should have a Karnofsky Performance Scale Score greater than or equal to 50
Exclusion
- Nursing or pregnant females
- Ages less than 15 years
Key Trial Info
Start Date :
June 18 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
645 Patients enrolled
Trial Details
Trial ID
NCT00922519
Start Date
June 18 2009
End Date
December 1 2012
Last Update
June 12 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada
2
Hamilton Health Sciences
Hamilton, Ontario, Canada
3
St. Joseph's Healthcare
Hamilton, Ontario, Canada
4
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, Canada